|
|
Volumn 66, Issue 3, 2002, Pages 115-121
|
|
Offspring of male and female parents with thalidomide embryopathy: Birth defects and functional anomalies
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
THALIDOMIDE;
HYPNOTIC SEDATIVE AGENT;
ADOLESCENT;
ADULT;
ARTICLE;
AUTISM;
BIRTH DEFECT;
CESAREAN SECTION;
CHILD;
CHILD HEALTH CARE;
CONGENITAL MALFORMATION;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
EMBRYOPATHY;
FEMALE;
FUNCTIONAL ASSESSMENT;
HUMAN;
INFANT;
MAJOR CLINICAL STUDY;
MALE;
MATERNAL CARE;
NEWBORN;
NEWBORN MORTALITY;
OUTPATIENT;
PELVIC DISEASE;
PREMATURITY;
PRIORITY JOURNAL;
PROGENY;
PULMONARY VALVE STENOSIS;
RACE DIFFERENCE;
RISK FACTOR;
SPONTANEOUS ABORTION;
UTERUS MALFORMATION;
FATHER;
GENETICS;
MOTHER;
PREGNANCY;
PRENATAL EXPOSURE;
PRESCHOOL CHILD;
SWEDEN;
ABNORMALITIES;
ABNORMALITIES, DRUG-INDUCED;
ADOLESCENT;
ADULT;
CHILD;
CHILD, PRESCHOOL;
FATHERS;
FEMALE;
HUMAN;
INFANT;
INFANT, NEWBORN;
MALE;
MOTHERS;
PREGNANCY;
PRENATAL EXPOSURE DELAYED EFFECTS;
SEDATIVES, NONBARBITURATE;
SUPPORT, NON-U.S. GOV'T;
SWEDEN;
THALIDOMIDE;
HUMANS;
HYPNOTICS AND SEDATIVES;
ILEX COOKII;
|
|
EID: 0036708517
PISSN: 00403709
EISSN: None
Source Type: Journal
DOI: 10.1002/tera.10083 Document Type: Article |
|
Times cited : (19)
|
|
References (35)
|
